Matthew Law

Active 1992–2025

170
Papers
32,241
Citations
94
h-index
161
i10-index

Citations

Citations per year for Matthew Law1983: 1 citations1986: 1 citations1992: 2 citations1993: 6 citations1994: 9 citations1995: 19 citations1996: 14 citations1997: 23 citations1998: 42 citations1999: 83 citations2000: 106 citations2001: 154 citations2002: 149 citations2003: 194 citations2004: 164 citations2005: 199 citations2006: 146 citations2007: 137 citations2008: 162 citations2009: 184 citations2010: 170 citations2011: 191 citations2012: 197 citations2013: 223 citations2014: 197 citations2015: 217 citations2016: 266 citations2017: 239 citations2018: 240 citations2019: 936 citations2020: 820 citations2021: 726 citations2022: 374 citations2023: 247 citations2024: 468 citations2025: 186 citations2026: 3 citations1984–1985: no citations, so these years are not shown1987–1991: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,903 citing papers, 25.3% of this breakdownUnited Kingdom: 1,036 citing papers, 9% of this breakdownAustralia: 848 citing papers, 7.4% of this breakdownItaly: 493 citing papers, 4.3% of this breakdownFrance: 462 citing papers, 4% of this breakdownCanada: 455 citing papers, 4% of this breakdownGermany: 377 citing papers, 3.3% of this breakdownSpain: 374 citing papers, 3.3% of this breakdownChina: 365 citing papers, 3.2% of this breakdownNetherlands: 320 citing papers, 2.8% of this breakdownSwitzerland: 282 citing papers, 2.4% of this breakdownSouth Africa: 261 citing papers, 2.3% of this breakdown
0%25.3%Other 28.7%

Fields

  • Medicine68.6%
  • Immunology and Microbiology11.2%
  • Biochemistry, Genetics and Molecular Biology8.3%
  • Psychology2.1%
  • Health Professions1.4%
  • Neuroscience1.3%
  • Other7.1%

Topics

  • HIV-related health complications and treatments7.9%
  • HIV Research and Treatment6.3%
  • HIV/AIDS Research and Interventions6.1%
  • HIV/AIDS drug development and treatment4.8%
  • Hepatitis C virus research3.6%
  • Liver Disease Diagnosis and Treatment2.2%
  • Other69.1%

Coauthors

All papers

Open in search
  1. Plasma Levels of Soluble CD14 Independently Predict Mortality in HIV Infection

    Authors: , , , , , , , , , , , , , , - The Journal of Infectious Diseases 2011 cited by 1,106

  2. Life expectancy of HIV‐positive people after starting combination antiretroviral therapy: a meta‐analysis

    Authors: , , , , - HIV Medicine 2016 cited by 427

  3. Cancer Incidence Before and After Kidney Transplantation

    Authors: , , , , , , , , , - JAMA 2006 cited by 1,120

  4. Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration

    Authors: , , , , , , , , , , , , , , , - The Lancet 2014 cited by 926

  5. Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regression

    Authors: , , , , , , , - Journal of Hepatology 2017 cited by 500

  6. Hepatitis C reinfection after successful antiviral treatment among people who inject drugs: A meta-analysis

    Authors: , , , , , , , , , , , , - Journal of Hepatology 2019 cited by 181

  7. Global estimates of viral suppression in children and adolescents and adults on antiretroviral therapy adjusted for missing viral load measurements: a multiregional, retrospective cohort study in 31 countries

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet HIV 2021 cited by 112

  8. The influence of sexual activity on the vaginal microbiota and Gardnerella vaginalis clade diversity in young women

    Authors: , , , , , , , , , , - PLoS ONE 2017 cited by 141

  9. Recommendations for next generation sequencing data reanalysis of unsolved cases with suspected Mendelian disorders: A systematic review and meta-analysis

    Authors: , , , , , , - Genetics in Medicine 2022 cited by 76

  10. Cardiovascular disease and use of contemporary protease inhibitors: the D:A:D international prospective multicohort study

    Authors: , , , , , , , , , , , , , , - The Lancet HIV 2018 cited by 220

  11. Risk of Myocardial Infarction in Patients with HIV Infection Exposed to Specific Individual Antiretroviral Drugs from the 3 Major Drug Classes: The Data Collection on Adverse Events of Anti‐HIV Drugs (D:A:D) Study

    Authors: , , , , , , , , , , , , , , - The Journal of Infectious Diseases 2009 cited by 647

  12. Contemporary antiretrovirals and body-mass index: a prospective study of the RESPOND cohort consortium

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lars Peters, Daniel Elbirt, Mario Sarcletti, Dominique L. Braun, Coca Necsoi, Cristina Mussini, Camilla Muccini, Natalie Bolokadze, Jennifer Hoy, Amanda Mocroft, Lene Ryom - The Lancet HIV 2021 cited by 62

  13. Direct-acting antiviral treatment for hepatitis C among people who use or inject drugs: a systematic review and meta-analysis

    Authors: , , , , , - ˜The œLancet. Gastroenterology & hepatology 2018 cited by 220

  14. Short‐term weight gain after antiretroviral therapy initiation and subsequent risk of cardiovascular disease and diabetes: the D:A:D study

    Authors: , , , , , , , , , , , , - HIV Medicine 2015 cited by 164

  15. Population effectiveness of opportunistic chlamydia testing in primary care in Australia: a cluster-randomised controlled trial

    Authors: , , , , , , , , , , , , - The Lancet 2018 cited by 104

  16. Incident Bacterial Vaginosis (BV) in Women Who Have Sex With Women Is Associated With Behaviors That Suggest Sexual Transmission of BV

    Authors: , , , , , , , , , , - Clinical Infectious Diseases 2014 cited by 91

  17. Incidence of hypertension in people with HIV who are treated with integrase inhibitors versus other antiretroviral regimens in the RESPOND cohort consortium

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - HIV Medicine 2022 cited by 65

  18. Declining hepatitis C virus-related liver disease burden in the direct-acting antiviral therapy era in New South Wales, Australia

    Authors: , , , , , , , , - Journal of Hepatology 2019 cited by 104

  19. The Mini-MAC

    Authors: , , , , , - Journal of Psychosocial Oncology 1994 cited by 389

  20. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

    Authors: , , , , , , - AIDS 1998 cited by 2,403

  21. Estimates of benefits and harms of prophylactic use of aspirin in the general population

    Authors: , , , , , , , , , , , , , , - Annals of Oncology 2014 cited by 387

  22. Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Susan M. Pond, David A. Cooper - Nature Medicine 2009 cited by 263

  23. The Coding Causes of Death in HIV (CoDe) Project

    Authors: , , , , , , , , , , , , , , - Epidemiology 2011 cited by 143

  24. Relation between HIV viral load and infectiousness: a model-based analysis

    Authors: , , , , - The Lancet 2008 cited by 366